N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin?-Reference-Cited by-同舟云学术

N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin?

Published:2023-07-25 Issue:11 Volume:27 Page:901-911
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Yoshimura Norito,Yamada Katsutoshi,Ono Takashi,Notoya Mitsuru,Yukioka Hideo,Takahashi Rina,Wakino Shu,Kanda Takeshi,Itoh Hiroshi

Funder

Shionogi

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10157-023-02379-1.pdf

Reference28 articles.

1. GBD 2013 Mortality and Causes of Death Collaborators. 2015 Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.

2. Ruiz-Ortega M, Lamas S, Ortiz A. Antifibrotic agents for the management of CKD: a review. Am J Kidney Dis. 2022;80:251–63.

3. Vanholder R, Glorieux G, De Smet R, et al. New insights in uremic toxins. Kidney Int. 2003;63:S6–10.

4. Vanholder R, Schepers E, Pletinck A, et al. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014;25:1897–907.

5. Vanholder R, De Smet R. Pathophysiologic effects of uremic retention solutes. J Am Soc Nephrol. 1999;10:1815–23.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to Guyton, J. R. & Boden, W. E.; Schreiber, S. et al.;Nature Medicine;2024-09-05

2. Metabolite accumulation from oral NMN supplementation drives aging-specific kidney inflammation;2024-04-13